药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Etidronic acid
Apremilast
The risk or severity of adverse effects can be increased when Aldosterone is combined with Apremilast.
Etidronic acid
Afelimomab
The risk or severity of adverse effects can be increased when Aldosterone is combined with Afelimomab.
Etidronic acid
Abatacept
The risk or severity of adverse effects can be increased when Abatacept is combined with Aldosterone.
Etidronic acid
Bleselumab
The risk or severity of adverse effects can be increased when Aldosterone is combined with Bleselumab.
Etidronic acid
Rozanolixizumab
The risk or severity of adverse effects can be increased when Aldosterone is combined with Rozanolixizumab.
Etidronic acid
Risankizumab
The risk or severity of adverse effects can be increased when Aldosterone is combined with Risankizumab.
Etidronic acid
Monomethyl fumarate
The risk or severity of adverse effects can be increased when Aldosterone is combined with Monomethyl fumarate.
Etidronic acid
Tetrandrine
The risk or severity of adverse effects can be increased when Aldosterone is combined with Tetrandrine.
Etidronic acid
Begelomab
The risk or severity of adverse effects can be increased when Aldosterone is combined with Begelomab.
Etidronic acid
9-(N-methyl-L-isoleucine)-cyclosporin A
The risk or severity of adverse effects can be increased when Aldosterone is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
Etidronic acid
Hypericin
The risk or severity of adverse effects can be increased when Aldosterone is combined with Hypericin.
Etidronic acid
Acteoside
The risk or severity of adverse effects can be increased when Aldosterone is combined with Acteoside.
Etidronic acid
Deoxyspergualin
The risk or severity of adverse effects can be increased when Aldosterone is combined with Deoxyspergualin.
Etidronic acid
Doxifluridine
The risk or severity of adverse effects can be increased when Aldosterone is combined with Doxifluridine.
Etidronic acid
Trofosfamide
The risk or severity of adverse effects can be increased when Aldosterone is combined with Trofosfamide.
Etidronic acid
Cepeginterferon alfa-2B
The risk or severity of adverse effects can be increased when Aldosterone is combined with Cepeginterferon alfa-2B.
Etidronic acid
Gusperimus
The risk or severity of adverse effects can be increased when Aldosterone is combined with Gusperimus.
Etidronic acid
Mizoribine
The risk or severity of adverse effects can be increased when Aldosterone is combined with Mizoribine.
Etidronic acid
Ozanimod
The risk or severity of adverse effects can be increased when Aldosterone is combined with Ozanimod.
Etidronic acid
Guselkumab
The risk or severity of adverse effects can be increased when Aldosterone is combined with Guselkumab.